MONDAY, Nov. 24, 2025 (HealthDay News) — Eli Lilly reached a major milestone Friday, becoming the first healthcare company in ...

The success of obesity drug Mounjaro turned Eli Lilly into the first $1 trillion drugmaker on Friday, while Danish rival Novo ...

Evan Seigerman, BMO head of health care research, joins 'The Exchange' to discuss the gap between Novo Nordisk and Eli Lilly, ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

The drugmaker became the first pharmaceutical company to hit a $1 trillion market capitalization. Booming deman ...

Now, let's consider whether a stock split may be in the cards for Lilly. As mentioned, the pharma giant has seen its stock ...

Healthcare giant Eli Lilly is now the first global healthcare company to hit $1 trillion in value riding on the popularity of ...

Eli Lilly posts 54% revenue growth with Zepbound, Mounjaro, expanding pipeline, and rising market share. Learn why LLY stock ...

Discover a portfolio update with insights on Eli Lilly, MP Materials, and Meta. Learn why these investment moves could boost ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, driven not only by outstanding earnings and a notable margin increase, but ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...